134 results on '"Bastida, José María"'
Search Results
2. Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
3. Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
4. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats
5. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
6. Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing
7. Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
8. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
9. Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
10. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant
11. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies
12. 170 Celiac disease in selective IgA deficiency patients is associated with T-cell defects
13. 174 Age-associated distribution of TH subsets in blood of LOCID vs CVID patients
14. Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
15. Inherited Thrombocytopenia Caused by Variants in Crucial Genes for Glycosylation
16. Platelet transcriptome analysis in patients with germline RUNX1 mutations
17. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
18. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction
19. Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies
20. Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models
21. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling
22. Novel therapies to address unmet needs in ITP
23. Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation
24. Novel variants in GALEcause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
25. Novel Therapies to Address Unmet Needs in ITP.
26. Inherited Platelet Disorders: An Updated Overview
27. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
28. Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model
29. A novel genetic variant inPTGS1affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis
30. Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag
31. Identification By Longread Nanopore Sequencing of a Complex Structural Variant in ITGB3 with a Founder Effect Causing Glanzmann's Thrombasthenia in Two Unrelated Patients
32. A novel nonsense variant in TPM4caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling
33. Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders
34. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology
35. Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag.
36. Biological Impact of Monoallelic and Biallelic BIRC3 Loss in Del(11q) Chronic Lymphocytic Leukemia Progression
37. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction
38. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis
39. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.
40. Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Therapy Related Myeloid Neoplasms: Comparative Study with a De Novo Myeloid Neoplasms Group
41. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center
42. Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice
43. Impact of Treatment on Overall Survival (OS) in Higher-Risk Myelodysplastic Syndromes (MDS): A Report from the Erasme Study
44. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis.
45. Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.
46. Assessment of the diagnoses of automated external defibrillators operated by basic life support personnel
47. Challenges for clinicians in ECG based retrospective resuscitation rhythm annotation
48. Reliability of ventilation guidance using capnography during ongoing chest compressions in out-of-hospital cardiopulmonary resuscitation
49. Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis
50. Evolution of AMSA for shock success prediction during the pre-shock pause
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.